跳至主要内容
临床试验/NCT03169829
NCT03169829撤回不适用

Safety and Efficacy of Plant-based Diets in Hemodialysis Patients

NYU Langone Health0 个研究点开始时间: 2019年1月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
主要终点
Pre-dialysis serum potassium concentrations.

研究概览

简要总结

The purpose of this proof-of-concept controlled-feeding study is to evaluate the impact of plant-rich diets, with and without high-potassium fruits and vegetables, on phosphorus and potassium homeostasis in hemodialysis (HD) patients.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Receiving thrice-weekly outpatient HD treatments for end-stage renal disease
  • 3-month mean serum potassium and phosphorus concentrations of >4.5 mEq/L and >4.0 mg/dL, respectively
  • No prior episodes of moderate-severe hyperkalemia (potassium ≥6.5 mEq/L) in the past 6 months
  • Deemed appropriate for the intervention by the patient's nephrologist, considering the patient's prognosis, cognition and pending treatments (e.g., kidney transplant)

排除标准

  • Change in medications that alter potassium homeostasis (e.g., RAAS inhibitors, diuretics, beta-blockers) in the last month
  • Diagnosed with bowel diseases or syndromes (e.g., bowel obstruction, major GI surgery, short-bowel syndrome, irritable bowel syndrome, inflammatory bowel disease, chronic diarrhea)
  • Anemic, defined as a serum hemoglobin concentration <9.0 g/dL
  • Inadequate dialysis efficacy, defined as a Kt/V of <1.2
  • Dietary restrictions (e.g., allergies) or otherwise unable/unwilling to adhere to study diets (excludes dietary restrictions on high-potassium foods)
  • Pregnant or planning to become pregnant during the study

研究组 & 干预措施

Hemodialysis Patients

Experimental

Phosphorus and potassium homeostasis will be assessed based on the concentrations of phosphorus and potassium in blood samples collected in fasting, post-prandial, mid-afternoon, pre-dialysis states, as well as the concentrations of phosphorus-regulatory factors, calcitriol, parathyroid hormone and fibroblast growth factor-23. The participants will be transitioned gradually to a plant-rich diet

干预措施: Standard Diet (Dietary Supplement)

Hemodialysis Patients

Experimental

Phosphorus and potassium homeostasis will be assessed based on the concentrations of phosphorus and potassium in blood samples collected in fasting, post-prandial, mid-afternoon, pre-dialysis states, as well as the concentrations of phosphorus-regulatory factors, calcitriol, parathyroid hormone and fibroblast growth factor-23. The participants will be transitioned gradually to a plant-rich diet

干预措施: Low-k (Dietary Supplement)

Hemodialysis Patients

Experimental

Phosphorus and potassium homeostasis will be assessed based on the concentrations of phosphorus and potassium in blood samples collected in fasting, post-prandial, mid-afternoon, pre-dialysis states, as well as the concentrations of phosphorus-regulatory factors, calcitriol, parathyroid hormone and fibroblast growth factor-23. The participants will be transitioned gradually to a plant-rich diet

干预措施: Standard (Dietary Supplement)

结局指标

主要结局

Pre-dialysis serum potassium concentrations.

时间窗: Day 1

Pre-dialysis blood samples will be collected by dialysis center staff, and delivered to the Tisch Laboratory by study staff on each dialysis day.

Pre-dialysis serum phosphorus concentrations.

时间窗: Day 7

Post-prandial blood tests will be obtained after the participant consumed the standard meal providing 20% of estimated energy requirements corresponding to the research diet

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验